Pharmaceutical

Stanford scientist who broke genome sequencing record o...

Stanford cardiologist Euan Ashley and his research team received a Guinness Worl...

Opinion: Living kidney donors rely on a promise to prot...

This change is profoundly unsettling to living kidney donors around the country.

Tanzania reports a Marburg outbreak, Africa’s second th...

Africa is grappling with not one, but two outbreaks of Marburg fever, a disease ...

Study finds same small rise in breast cancer risk in ma...

A study finds that the slightly elevated risk of breast cancer doesn't change wi...

The new frontiers of pharmaceutical innovation – accord...

A combination of economic turbulence and rapid technological advances means inve...

Africa: Unleashing the potential of the new superpower ...

Africa remains a largely untapped market for clinical trials, with data showing ...

BioNTech and OncoC4 sign deal to co-develop antibody fo...

BioNTech and OncoC4 will co-develop OncoC4’s ONC-392 as a monotherapy or combina...

Predictive Oncology partners with Cancer Research Horizons

Predictive Oncology’s PEDAL platform enables more informed selection of drug-tum...

Race for a first-to-market therapy for NASH heats up

The strategic efforts from two companies have raised the profile of NASH, an ind...

RVAC and University of Pennsylvania to develop mRNA vac...

The partnership will focus on developing mRNA vaccines to treat certain autoimmu...

CMO Moves: Regulatory catalysts for drug manufacturing ...

Pharmaceutical Technology analyses recent regulatory and trial announcements tha...

InvisiShield and Gladstone partner to develop intranasa...

The collaboration will develop intranasal preventatives for influenza, respirato...

Cannabidiol milling: Selecting the right equipment for ...

The therapeutic properties of Cannabidiol (CBD) - a pure natural ingredient extr...

Gilead Sciences to exclusively license Nurix Therapeuti...

GS-6791 is the first development candidate from the previous collaboration betwe...

STAT+: Senator calls for probe of conflict of interest ...

One panelist was paid nearly $27,000 in recent years by Novo Nordisk, which sell...

Arizona plans to dramatically increase hepatitis C test...

The Arizona Department of Corrections is promising a federal judge that it will ...